~~<i id='25BFF3CA90'><strike id='25BFF3CA90'><tt id='25BFF3CA90'><pre id='25BFF3CA90'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

hotspot

focus

author：explore 2025-09-29 20:17:41 - browse：69

A European regulatory panel has recommended against approval of a lung cancer drug made by Mirati Therapeutics, the company said Friday.

Mirati said it will appeal the negative opinion of the drug, called Krazati, issued by a committee of the European Medicines Agency that met this week. But for now, the adverse decision is likely to be adopted by European regulators and prevent the company from marketing the pill in Europe.

Krazati works by blocking a specific type of KRAS alteration called G12C, found in approximately 13% of lung tumors.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Alkermes shareholders re
Next article： NYC stabbing: Teen named, arraigned by District Attorney in O'Shae Sibley death

focus

knowledge

focus

hotspot

leisure time

1:56ThresholdGlassJarCandlessoldexclusivelybyTarget.U.S.ConsumerProductSafetyCommissionTargethasreca

WSS

Some of the ways extreme heat will change life as we know it

Maui funeral service workers on devastation of fires: 'I'm in shock'

O'Shea Sibley was killed after expressing queer joy by voguing, activists say

Target recalls 2.2 million additional candles due to laceration, burn hazards

Large hospital system sues Multiplan for low

'Disease catastrophe' looms in Sudan as health conditions deteriorate, medics warn

hotspot

focus

focus

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Maui funeral service workers on devastation of fires: 'I'm in shock'

Dobbs anniversary: the lost opportunity of abortion as health care

Novo acquires Inversago for up to $1 billion

Dobbs anniversary: the lost opportunity of abortion as health care

Pharma budget tightening trickles down to Doximity

Psychedelics group wrestles with new pharma identity

Presidential candidate assassinated in Ecuador, 1 suspect dead and 6 arrested

Anesthesiologist group: stop taking Ozempic before surgery

Large hospital system sues Multiplan for low

knowledge

Trump, Nauta plead not guilty to new classified docs charges but De Oliveira still not arraigned

GOP presidential candidates start declaring their loyalty

Who are the detained American citizens released from prison in Iran?

O'Shea Sibley was killed after expressing queer joy by voguing, activists say

Kim Kardashian sparks debate on benefits of full

NYC stabbing: Teen named, arraigned by District Attorney in O'Shae Sibley death

focus

focus

hotspot

leisure time